BionTech Covid-19 Vaccine

BionTech Covid-19 Vaccine

"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, chief executive of the company.  Photo: Collected

China likely to approve BioNTech's Covid-19 vaccine by July - WSJ

If approved, it would become the first foreign Covid-19 vaccine to be authorised in the country

Unilever gets vaccine partnership offers as it plots worker safety strategy

Unilever gets vaccine partnership offers as it plots worker safety strategy

"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, chief executive of the company.  Photo: Collected

BioNTech aims for 2 billion Covid-19 vaccine doses in 2021

"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, chief executive of the company.  Photo: Collected

BioNTech founders warn of vaccine supply gaps

"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, chief executive of the company.  Photo: Collected

China's Fosun plans plant to make BioNTech's Covid-19 vaccine -Caixin

Pharmacist Susanne Wohlgemuth prepares Pfizer/BioNTech Covid-19 vaccinations at the Haus an der Linde nursing home in Lichtentanne, Saxony, Germany December 27, 2020, the day when the country starts its vaccination programme. Hendrik Schmidt/Pool via Reuters

EU starts mass vaccination in 'touching moment of unity'

Mutated Covid-19 variant could make herd immunity more difficult: BioNTech boss

Mutated Covid-19 variant could make herd immunity more difficult: BioNTech boss

Photo: Collected.

UK approves Pfizer-BioNTech vaccine for use

The question arises whether a member state would want to administer to its citizens a vaccine that has not been reviewed by EMA Photo: Collected

Covid-19 vaccine: The next steps

A man wearing a protective face mask walks past the logo of Sanofi at the company's headquarters in Paris, France, April 24, 2020/ Reuters

Sanofi says its vaccine won’t need supercooling

Ugur Sahin, CEO and co-founder of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany September 17, 2020. REUTERSFabian BimmerFile Photo

Vaccine scientist hopes for return to ‘normal’ by next winter

Ugur Sahin, CEO and co-founder of German biotech firm BioNTech. Picture: Reuters

Covid-19: BioNTech CEO says normal life by next winter

A worker passes a line of freezers holding coronavirus disease (Covid-19) vaccine candidate BNT162b2 at a Pfizer facility in Puurs, Belgium in an undated photograph. Pfizer/Handout via REUTERS

Vaccine is inexact bonus for freight and freezers